Keith Lenden

Keith Lenden has worked in the biotechnology industry since 2001. Keith began their career at Genteric as the Director of Business Development in 2001. In 2004, they moved to Acologix as Senior Director of Business Development. In 2007, they became the Vice President of Product & Business Development at Maxygen. From 2008 to 2011, they were the Co-Founder of Receptos. Keith then moved to Abide Therapeutics as Co-Founder in 2011. In 2013, they became the Vice President of Corporate Development & Strategy at Esperion Therapeutics. In 2018, they Co-Founded both Autobahn Therapeutics, Inc. and Boundless Bio. Keith Lenden is currently the Co-Founder & CEO of Asteroid Therapeutics, as well as a Venture Partner at ARCH Venture Partners.

Keith Lenden received a Jeff Timmons Leadership Award from Kauffman Fellow in 2013. Keith then went on to earn an MBA from the University of California, Berkeley, Haas School of Business in 2001. Prior to that, they received a BE from the Thayer School of Engineering, Dartmouth College in 1995 and a BA from Dartmouth College in 1995, both in Engineering.